Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)

Stopped Slow accrual of subjects. May take longer than expected to complete the trial.

Conditions

• Dry Eye
• Ocular Graft vs Host Disease
• Meibomian Gland Dysfunction

Interventions

• DRUG: Brimonidine 0.15%
• DRUG: Brimonidine 0.075%
• DRUG: Placebo

Sponsor

Sandeep Jain, MD

Collaborators

• [object Object]